Management of T1b esophagogastric adenocarcinoma: interpreting the CONGRESS study
Diseases of the Esophagus · 02.11.2026 · 39 (6)
DOI: 10.1093/dote/doag125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 13.11.2026. Verfasst von Yuto Shimamura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Austin Health, The University of Melbourne, Melbourne, VIC, Australia. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.
- Division of Gastroenterology and Baylor Scott & White Center for Esophageal Diseases at Baylor University Medical Center, Dallas, TX, USA.
Zitieren
APA
Shimamura, Y., & Konda, V. J. A. (2026). Management of T1b esophagogastric adenocarcinoma: interpreting the CONGRESS study. Diseases of the Esophagus, 39(6). https://doi.org/10.1093/dote/doag125
Vancouver
Shimamura Y, Konda VJA. Management of T1b esophagogastric adenocarcinoma: interpreting the CONGRESS study. Diseases of the Esophagus. 2026;39(6). doi:10.1093/dote/doag125
BibTeX
@article{Shimamura2026,
author = {Shimamura, Yuto and Konda, Vani J A},
title = {Management of T1b esophagogastric adenocarcinoma: interpreting the CONGRESS study},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {6},
doi = {10.1093/dote/doag125}
}
EUVIMED